Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Prediction of outcome after diagnosis of metachronous contralateral breast cancer.

Alkner S, Bendahl PO, Fernö M, Manjer J, Rydén L.

BMC Cancer. 2011 Mar 30;11:114. doi: 10.1186/1471-2407-11-114.

2.

Patterns of metastasis in women with metachronous contralateral breast cancer.

Vichapat V, Garmo H, Holmberg L, Fentiman IS, Tutt A, Gillett C, Lüchtenborg M.

Br J Cancer. 2012 Jul 10;107(2):221-3. doi: 10.1038/bjc.2012.273. Epub 2012 Jun 26.

3.

Prognosis, stage and oestrogen receptor status of contralateral breast cancer in relation to characteristics of the first tumour, prior endocrine treatment and radiotherapy.

Alkner S, Ehinger A, Bendahl PO, Rydén L, Fernö M.

Eur J Cancer. 2015 Nov;51(16):2304-13. doi: 10.1016/j.ejca.2015.07.016. Epub 2015 Aug 1.

PMID:
26243193
4.

Metachronous contralateral breast cancer as first event of relapse.

de la Rochefordière A, Mouret-Fourme E, Asselain B, Scholl SM, Campana F, Broët P, Fourquet A.

Int J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):615-21.

PMID:
8948346
5.

Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study.

Vichapat V, Garmo H, Holmqvist M, Liljegren G, Wärnberg F, Lambe M, Fornander T, Adolfsson J, Lüchtenborg M, Holmberg L.

J Clin Oncol. 2012 Oct 1;30(28):3478-85. Epub 2012 Aug 27.

6.

Relation of risk of contralateral breast cancer to the interval since the first primary tumour.

Rubino C, Arriagada R, Delaloge S, Lê MG.

Br J Cancer. 2010 Jan 5;102(1):213-9. doi: 10.1038/sj.bjc.6605434. Epub 2009 Nov 17.

7.

Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer.

Sandberg ME, Hartman M, Klevebring D, Eloranta S, Ploner A, Hall P, Czene K.

Breast Cancer Res Treat. 2012 Jul;134(2):793-800. doi: 10.1007/s10549-012-2096-3. Epub 2012 May 24.

PMID:
22622811
8.

Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses.

Vichapat V, Garmo H, Holmberg L, Fentiman IS, Tutt A, Gillett C, Lüchtenborg M.

Breast Cancer Res Treat. 2011 Nov;130(2):609-18. doi: 10.1007/s10549-011-1618-8. Epub 2011 Jun 14.

PMID:
21671018
9.

[Contralateral breast cancer: metastasis or second primary cancer?].

Broët P, de la Rochefordière A, Scholl SM, Fourquet A, Mosseri V, Durand JC, Pouillart P, Asselain B.

Bull Cancer. 1996 Oct;83(10):870-6. Review. French.

PMID:
8952638
10.

Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.

Heron DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield CM.

Cancer. 2000 Jun 15;88(12):2739-50.

PMID:
10870056
11.

Influence of radiotherapy for the first tumor on aggressiveness of contralateral breast cancer.

Sandberg ME, Alkner S, Hartman M, Eloranta S, Rydén L, Ploner A, Adami HO, Hall P, Czene K.

Int J Cancer. 2013 May 15;132(10):2388-94. doi: 10.1002/ijc.27890. Epub 2012 Oct 29.

12.

Risk factors for contralateral breast cancer in Chennai (Madras), India.

Gajalakshmi CK, Shanta V, Hakama M.

Int J Epidemiol. 1998 Oct;27(5):743-50.

13.

Contralateral breast cancer: clinical characteristics and impact on prognosis.

Healey EA, Cook EF, Orav EJ, Schnitt SJ, Connolly JL, Harris JR.

J Clin Oncol. 1993 Aug;11(8):1545-52.

PMID:
8336193
14.

Risk factors for metachronous contralateral breast cancer suggest two aetiological pathways.

Vichapat V, Gillett C, Fentiman IS, Tutt A, Holmberg L, Lüchtenborg M.

Eur J Cancer. 2011 Sep;47(13):1919-27. doi: 10.1016/j.ejca.2011.05.004. Epub 2011 Jun 12.

PMID:
21658939
15.

Prognostic significance of synchronous and metachronous bilateral breast cancer.

Kollias J, Ellis IO, Elston CW, Blamey RW.

World J Surg. 2001 Sep;25(9):1117-24.

PMID:
11571945
16.

Contralateral breast cancer: annual incidence and risk parameters.

Broët P, de la Rochefordière A, Scholl SM, Fourquet A, Mosseri V, Durand JC, Pouillart P, Asselain B.

J Clin Oncol. 1995 Jul;13(7):1578-83.

PMID:
7602346
17.

The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands.

Schaapveld M, Visser O, Louwman WJ, Willemse PH, de Vries EG, van der Graaf WT, Otter R, Coebergh JW, van Leeuwen FE.

Breast Cancer Res Treat. 2008 Jul;110(1):189-97. Epub 2007 Aug 9.

18.

Clinical and histological predictors of contralateral breast cancer.

Kollias J, Ellis IO, Elston CW, Blamey RW.

Eur J Surg Oncol. 1999 Dec;25(6):584-9.

PMID:
10556004
19.

Second primary in the contralateral breast after treatment of breast cancer.

Yadav BS, Sharma SC, Patel FD, Ghoshal S, Kapoor RK.

Radiother Oncol. 2008 Feb;86(2):171-6. Epub 2007 Oct 24.

PMID:
17961777
20.

Increased risk of contralateral breast cancers among overweight and obese women: a time-dependent association.

Majed B, Dozol A, Ribassin-Majed L, Senouci K, Asselain B.

Breast Cancer Res Treat. 2011 Apr;126(3):729-38. doi: 10.1007/s10549-010-1153-z. Epub 2010 Sep 26.

PMID:
20872242
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk